National Cancer Institute; Notice of Closed Meetings, 76981 [2011-31679]

Download as PDF Federal Register / Vol. 76, No. 237 / Friday, December 9, 2011 / Notices SES Non-SES Catherine Beck Susan Bernard Malcolm Bertoni Eric Blumberg Beverly Chernaik Dara Corrigan Kathleen Crosby L’Tonya Davis David Elder Denise Esposito Tracy Forfa Lillian Gill Deborah Henderson Kimberly Holden Jeanne Ireland Melanie Keller Michael Landa Caroline Lewis Eric Lindblom Mary Anne Malarkey Diane Maloney Daniel McChesney William McConagha Patrick McGarey Ruth McKee Alfred R. Miller Theresa Mullin Deanna Murphy Melinda Plaisier Lynne Rice Mark Roh James Sigg Steven Silverman Howard Sklamberg Philip Spiller Nancy Stade John Taylor Michael Taylor Brian Trent Mary Lou Valdez Steven Vaughn Stephen Veneruso Helen Winkle Ann Wion Bernadette Dunham Ted Elkin Jeff Farrar William Flynn Christy Foreman Malcolm Frazier Alberto Gutierrez Sheryl Lard-Whiteford Murray Lumpkin William Maisel Karen Midthun Ellen Morrison Steven Musser Steven Pollack Jonathan Sackner-Bernstein Barbara Schneeman Rachel Sherman Jeffrey Shuren Ann Simoneau William Slikker Steven Solomon Stephen Spielberg Roberta Wagner David White Carolyn Wilson Janet Woodcock Robert Yetter Donald Zink Dated: December 1, 2011. Margaret A. Hamburg, Commissioner of Food and Drugs. [FR Doc. 2011–31579 Filed 12–8–11; 8:45 am] srobinson on DSK4SPTVN1PROD with NOTICES BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as VerDate Mar<15>2010 18:35 Dec 08, 2011 Jkt 226001 amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, NCI SPORE in Prostate and Gastrointestinal Cancers. Date: February 15–16, 2012. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Caron A Lyman, PhD, Scientific Review Officer, National Cancer Institute, NIH, Division of Extramural Activities, Research Programs Review Branch, 6116 Executive Blvd., Room 8119, Bethesda, MD 20892–8328, (301) 451–4761, lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, International Tobacco and Health Research and Capacity Building Program. Date: February 28–29, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Gerald G. Lovinger, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8055A, Bethesda, MD 20892–8329, (301) 496–7987, lovingeg@mail.nih.gov. Name of Commitee: National Cancer Institute Special Emphasis Panel, Small Grants Program for Cancer Epidemiology. Date: March 22–23, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Jeffrey E. DeClue, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8059, Bethesda, MD 20892–8329, (301) 496–7904, decluej@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Nanotechnology Reformulations for Cancer Drugs. PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 76981 Date: April 12, 2012. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Jeffrey E. DeClue, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8059, Bethesda, MD 20892–8329, (301) 496–7904, decluej@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: December 5, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–31679 Filed 12–8–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY [Docket No. DHS–2011–0115] Request for Public Comments Concerning U.S.-Canada Action Plan for Perimeter Security and Economic Competitiveness Office of Policy, DHS. Notice. AGENCY: ACTION: The United States and Canada are staunch allies, vital economic partners, neighbors, and steadfast friends. We share common values, communities, and deep links among our citizens. The extensive mobility of people, goods, capital, and information between our two countries has helped ensure that our societies remain open, democratic, prosperous, and secure. On February 4, 2011, President Barack Obama and Canadian Prime Minister Stephen Harper announced Beyond the Border: A Shared Vision for Perimeter Security and Economic Competitiveness. This declaration describes a perimeter approach to security in which the United States and Canada share responsibility for the security and resilience of our nations. SUMMARY: E:\FR\FM\09DEN1.SGM 09DEN1

Agencies

[Federal Register Volume 76, Number 237 (Friday, December 9, 2011)]
[Notices]
[Page 76981]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-31679]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI SPORE in Prostate and Gastrointestinal Cancers.
    Date: February 15-16, 2012.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Caron A Lyman, PhD, Scientific Review Officer, 
National Cancer Institute, NIH, Division of Extramural Activities, 
Research Programs Review Branch, 6116 Executive Blvd., Room 8119, 
Bethesda, MD 20892-8328, (301) 451-4761, lymanc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, International Tobacco and Health Research and Capacity 
Building Program.
    Date: February 28-29, 2012.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Gerald G. Lovinger, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Room 8055A, Bethesda, MD 20892-8329, (301) 496-7987, 
lovingeg@mail.nih.gov.

    Name of Commitee: National Cancer Institute Special Emphasis 
Panel, Small Grants Program for Cancer Epidemiology.
    Date: March 22-23, 2012.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Jeffrey E. DeClue, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8059, Bethesda, MD 20892-8329, (301) 496-7904, 
decluej@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Nanotechnology Reformulations for Cancer Drugs.
    Date: April 12, 2012.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Jeffrey E. DeClue, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8059, Bethesda, MD 20892-8329, (301) 496-7904, 
decluej@mail.nih.gov.
    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 5, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-31679 Filed 12-8-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.